Phorbol-12-myristate 13-acetate acting through protein kinase Cε induces translocator protein (18-kDa) Tspo gene expression

Biochemistry

Volumn 47, Issue 48, 2008, Pages 12886-12899

  Batarseh, Amani ^a,b   Giatzakis, Christoforos ^a   Papadopoulos, Vassilios ^a,b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; BINDING SITES; CELL CULTURE; CELL PROLIFERATION; CHEMICAL ACTIVATION; CYTOLOGY; ELECTROPHORETIC MOBILITY; GENE EXPRESSION; PNEUMATIC CONTROL EQUIPMENT; TRANSCRIPTION; TRANSCRIPTION FACTORS;

3T3 CELLS; ACTIVATOR PROTEINS; BINDING PROTEINS; CANCER CELLS; CELL LINES; CONSTITUTIVE EXPRESSIONS; ELECTROPHORETIC MOBILITY SHIFT ASSAYS; IN CELLS; INHIBITION PROFILES; MRNA LEVELS; OVEREXPRESSION; PROMOTER ACTIVITIES; PROTEIN KINASE C; SPECIFIC INHIBITORS; STEROIDOGENESIS; STIMULATORY EFFECTS; TRANSCRIPTION START SITES; TRANSCRIPTIONAL ACTIVITIES; TRANSCRIPTIONAL RESPONSES; TRANSLOCATOR; UP REGULATIONS;

CELLS;

CARRIER PROTEIN; CHOLESTEROL BINDING PROTEIN; GA BINDING PROTEIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN C JUN; PROTEIN KINASE C EPSILON; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR ETS; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CELL STRAIN COS7; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; LEYDIG CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; TRANSCRIPTION REGULATION; TSPO GENE;

ANIMALS; BASE SEQUENCE; BINDING SITES; CERCOPITHECUS AETHIOPS; COS CELLS; GA-BINDING PROTEIN TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; MICE; NIH 3T3 CELLS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN KINASE C-EPSILON; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, GABA; RNA, MESSENGER; RNA, SMALL INTERFERING; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 57049093333     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi8012643     Document Type: Article

References (49)

1. Papadopoulos, V., Baraldi, M., Guilarte, T. R., Knudsen, T. B., Lacapere, J. J., Lindemann, P., Norenberg, M. D., Nutt, D., Weizman, A., Zhang, M. R., and Gavish, M. (2006) Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 27, 402-409.
2. Braestrup, C., and Squires, R. F. (1977) Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc. Natl. Acad. Sci. U.S.A. 74, 3805-3809.
3. Casellas, P., Galiegue, S., and Basile, A. S. (2002) Peripheral benzodiazepine receptors and mitochondrial function. Neurochem. Int. 40, 475-486.
4. Gavish, M., Bachman, I., Shoukrun, R., Katz, Y., Veenman, L., Weisinger, G., and Weizman, A. (1999) Enigma of the peripheral benzodiazepine receptor. Pharmacol. Rev. 51, 629-650.
5. Giatzakis, C., and Papadopoulos, V. (2004) Differential utilization of the promoter of peripheral-type benzodiazepine receptor by steroidogenic versus nonsteroidogenic cell lines and the role of Sp1 and Sp3 in the regulation of basal activity. Endocrinology 145, 1113-1123.
6. Hardwick, M., Fertikh, D., Culty, M., Li, H., Vidic, B., and Papadopoulos, V. (1999) Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res. 59, 831-842.
7. Han, Z., Slack, R. S., Li, W., and Papadopoulos, V. (2003) Expression of peripheral benzodiazepine receptor (PBR) in human tumors: relationship to breast, colorectal, and prostate tumor progression. J. Recept. Signal Transduct. Res. 23, 225-238.
8. Galiegue, S., Casellas, P., Kramar, A., Tinel, N., and Simony-Lafontaine, J. (2004) Immunohistochemical assessment of the peripheral benzodiazepine receptor in breast cancer and its relationship with survival. Clin. Cancer Res. 10, 2058-2064.
9. Maaser, K., Grabowski, P., Sutter, A. P., Hopfner, M., Foss, H. D., Stein, H., Berger, G., Gavish, M., Zeitz, M., and Scherubl, H. (2002) Overexpression of the peripheral benzodiazepine receptor is a relevant prognostic factor in stage III colorectal cancer. Clin. Cancer Res. 8, 3205-3209.
10. Katz, Y., Ben-Baruch, G., Kloog, Y., Menczer, J., and Gavish, M. (1990) Increased density of peripheral benzodiazepine-binding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovaries. Clin. Sci. 78, 155-158.
11. Veenman, L., Papadopoulos, V., and Gavish, M. (2007) Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr. Pharm. Des. 13 (23), 2385-405.
12. Gazouli, M., Yao, Z. X., Boujrad, N., Corton, J. C., Culty, M., and Papadopoulos, V. (2002) Effect of peroxisome proliferators on Leydig cell peripheral-type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: role of the peroxisome proliferator-activator receptor alpha. Endocrinology 143, 2571-2583.
13. Amri, H., Drieu, K., and Papadopoulos, V. (2003) Transcriptional suppression of the adrenal cortical peripheral-type benzodiazepine receptor gene and inhibition of steroid synthesis by ginkgolide B. Biochem. Pharmacol. 65, 717-729.
14. Giatzakis, C., Batarseh, A., Dettin, L., and Papadopoulos, V. (2007) The role of Ets transcription factors in the basal transcription of the translocator protein (18 kDa). Biochemistry 46, 4763-4774.
15. Furstenberger, G., Berry, D. L., Sorg, B., and Marks, F. (1981) Skin tumor promotion by phorbol esters is a two-stage process. Proc. Natl. Acad. Sci. U.S.A. 78, 7722-7726.
16. Saito, N., Kikkawa, U., and Nishizuka, Y. (2002) The family of protein kinase C and membrane lipid mediators. J. Diabetes Complications 16, 4-8.
17. Nishizuka, Y. (1988) The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334, 661-665.
18. Wetsel, W. C., Khan, W. A., Merchenthaler, I., Rivera, H., Halpern, A. E., Phung, H. M., Negro-Vilar, A., and Hannun, Y. A. (1992) Tissue and cellular distribution of the extended family of protein kinase C isoenzymes. J. Cell Biol. 117, 121-133.
19. da Rocha, A. B., Mans, D. R., Regner, A., and Schwartsmann, G. (2002) Targeting protein kinase C: new therapeutic opportunities against high-grade malignant gliomas? Oncologist 7, 17-33.
20. Lopez-Ruiz, M. P., Choi, M. S., Rose, M. P., West, A. P., and Cooke, B. A. (1992) Direct effect of arachidonic acid on protein kinase C and LH-stimulated steroidogenesis in rat Leydig cells; evidence for tonic inhibitory control of steroidogenesis by protein kinase C. Endocrinology 130 (3), 1122-1130.
21. Manna, P. R., Jo, Y., and Stocco, D. M. (2007) Regulation of Leydig cell steroidogenesis by extracellular signal-regulated kinase 1/2: role of protein kinase A and protein kinase C signaling. J. Endocrinol. 193 (1), 53-63.
22. Jo, Y., King, S. R., Khan, S. A., and Stocco, D. M. (2005) Involvement of protein kinase C and cyclic adenosine 3′,5′-monophosphate-dependent kinase in steroidogenic acute regulatory protein expression and steroid biosynthesis in Leydig cells. Biol. Reprod. 73 (2), 244-55.
23. Griner, E. M., and Kazanietz, M. G. (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat. Rev. Cancer 7, 281-294.
24. Ono, Y., Fujii, T., Ogita, K., Kikkawa, U., Igarashi, K., and Nishizuka, Y. (1988) The structure, expression, and properties of additional members of the protein kinase C family. J. Biol. Chem. 263, 6927-6932.
25. Papadopoulos, V., Amri, H., Li, H., Boujrad, N., Vidic, B., and Garnier, M. (1997) Targeted disruption of the peripheral-type benzodiazepine receptor gene inhibits steroidogenesis in the R2C Leydig tumor cell line. J. Biol. Chem. 272, 32129-32135.
26. Li, H., Yao, Z., Degenhardt, B., Teper, G., and Papadopoulos, V. (2001) Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc. Natl. Acad. Sci. U.S.A. 98, 1267-1272.
27. Delavoie, F., Li, H., Hardwick, M., Robert, J. C., Giatzakis, C., Peranzi, G., Yao, Z. X., Maccario, J., Lacapere, J. J., and Papadopoulos, V. (2003) In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. Biochemistry 42, 4506-4519.
28. Birchall, A. M., Bishop, J., Bradshaw, D., Cline, A., Coffey, J., Elliott, L. H., Gibson, V. M., Greenham, A., Hallam, T. J., and Harris, W. (1994) Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activation. J. Pharmacol. Exp. Ther. 268, 922-929.
29. Koyama, N., Kashimata, M., Sakashita, H., Sakagami, H., and Gresik, E. W. (2003) EGF-stimulated signaling by means of PI3K, PLCgamma1, and PKC isozymes regulates branching morphogenesis of the fetal mouse submandibular gland. Dev. Dyn. 227, 216-226.
30. Gadea, A., Schinelli, S., and Gallo, V. (2008) Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK/c-Jun signaling pathway. J. Neurosci. 28, 2394-2408.
31. Fabbro, D., Kung, W., Roos, W., Regazzi, R., and Eppenberger, U. (1986) Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship. Cancer Res. 46, 2720-2725.
32. Platet, N., Prevostel, C., Derocq, D., Joubert, D., Rochefort, H., and Garcia, M. (1998) Breast cancer cell invasiveness: correlation with protein kinase C activity and differential regulation by phorbol ester in estrogen receptor-positive and -negative cells. Int. J. Cancer 75, 750-756.
33. Lahn, M., Sundell, K., Gleave, M., Ladan, F., Su, C., Li, S., Ma, D., Paterson, B. M., and Bumol, T. F. (2004) Protein kinase C-alpha in prostate cancer. BJU Int. 93, 1076-1081.
34. Nakamura, J., Suda, T., Ogawa, Y., Takeo, T., Suga, S., and Wakui, M. (2001) Protein kinase C-dependent and -independent inhibition of Ca(2+) influx by phorbol ester in rat pancreatic beta-cells. Cell Signal. 13, 199-205.
35. Ikeda, Y., Olsen, G. S., Ziv, E., Hansen, L. L., Busch, A. K., Hansen, B. F., Shafrir, E., and Mosthaf-Seedorf, L. (2001) Cellular mechanism of nutritionally induced insulin resistance in Psammomys obesus: overexpression of protein kinase C epsilon in skeletal muscle precedes the onset of hyperinsulinemia and hyperglycemia. Diabetes 50, 584-592.
36. Kinouchi, T., Sorimachi, H., Maruyama, K., Mizuno, K., Ohno, S., Ishiura, S., and Suzuki, K. (1995) Conventional protein kinase C (PKC)-alpha and novel PKC epsilon, but not -delta, increase the secretion of an N-terminal fragment of Alzheimer's disease amyloid precursor protein from PKC cDNA transfected 3Y1 fibroblasts. FEBS Lett. 364, 203-206.
37. Bae, K. M., Wang, H., Jiang, G., Chen, M. G., Lu, L., and Xiao, L. (2007) Protein kinase C epsilon is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner. Cancer Res. 67, 6053-6063.
38. Aziz, M. H., Manoharan, H. T., and Verma, A. K. (2007) Protein kinase C epsilon, which sensitizes skin to sun's UV radiation-induced cutaneous damage and development of squamous cell carcinomas, associates with Stat3. Cancer Res. 67, 1385-1394.
39. Pan, Q., Bao, L. W., Teknos, T. N., and Merajver, S. D. (2006) Targeted disruption of protein kinase C ε reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma. Cancer Res. 66, 9379-9384.
40. Perletti, G. P., Concari, P., Brusaferri, S., Marras, E., Piccinini, F., and Tashjian, A. H. (1998) Protein kinase C epsilon is oncogenic in colon epithelial cells by interaction with the ras signal transduction pathway. Oncogene 16, 3345-3348.
41. Wu, D., Foreman, T. L., Gregory, C. W., McJilton, M. A., Wescott, G. G., Ford, O. H., Alvey, R. F., Mohler, J. L., and Terrian, D. M. (2002) Protein kinase cepsilon has the potential to advance the recurrence of human prostate cancer. Cancer Res. 62, 2423-2429.
42. Pan, Q., Bao, L. W., Kleer, C. G., Sabel, M. S., Griffith, K. A., Teknos, T. N., and Merajver, S. D. (2005) Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy. Cancer Res. 65, 8366-8371.
43. Basu, A., Mohanty, S., and Sun, B. (2001) Differential sensitivity of breast cancer cells to tumor necrosis factor-alpha: involvement of protein kinase C. Biochem. Biophys. Res. Commun. 280, 883-891.
44. Li, W., Hardwick, M. J., Rosenthal, D., Culty, M., and Papadopoulos, V. (2007) Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation. Biochem. Pharmacol. 73, 491-503.
45. Lacapere, J. J., and Papadopoulos, V. (2003) Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. Steroids 68, 569-585.
46. Hodge, C. W., Raber, J., McMahon, T., Walter, H., Sanchez-Perez, A. M., Olive, M. F., Mehmert, K., Morrow, A. L., and Messing, R. O. (2002) Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon. J. Clin. Invest. 110, 1003-1010.
47. Hofmann, J. (2001) Modulation of protein kinase C in antitumor treatment. Rev. Physiol. Biochem. Pharmacol. 142, 1-96.
48. Cai, H., Smola, U., Wixler, V., Eisenmann-Tappe, I., az-Meco, M. T., Moscat, J., Rapp, U., and Cooper, G. M. (1997) Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase. Mol. Cell. Biol. 17, 732-741.
49. Mischak, H., Goodnight, J. A., Kolch, W., Martiny-Baron, G., Schaechtle, C., Kazanietz, M. G., Blumberg, P. M., Pierce, J. H., and Mushinski, J. F. (1993) Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J. Biol. Chem. 268, 6090-6096.